4160 Barrel domain in thermophilic metalloproteases (M29)
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organoheterocyclic compounds | 2 | 0.6 | 3.29× | not tested | |
| Homogeneous metal compounds | 4 | 1.9 | 2.07× | not tested | |
| Organic acids and derivatives | 1 | 0.6 | 1.64× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00145 | GLY | Glycine | 2 |
| DB00150 | TRP | Tryptophan | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FE2metal | FE (II) ION | 12 |
| ZNmetal | ZINC ION | 11 |
| FEmetal | FE (III) ION | 6 |
| G6C | 5-oxidanyl-1H-pyridin-2-one | 4 |
| D6O | (~{Z})-4-formamido-4-oxidanylidene-but-2-enoic acid | 2 |
| GLY | GLYCINE | 2 |
| TRP | TRYPTOPHAN | 2 |
| COmetal | COBALT (II) ION | 1 |